Genmab — Maj 2019

[Sukkeralf]

https://www.primeoncology.org/app/uploads/wcc-2018-webcast-kumar-prime-oncology.pdf

[peter12]

Dialyse koster ca 400k pr år plus den gene det giver patienten , og det rammer ca 40%.

[Monforte]

@EL , On tuesday I’m receiving Dara for the 66. time. The last 3.5 year without Rd additive:-) and without signs of MM. For me Dara was the solution!

[E_L]

wow! that is really nice to hear! so how long in total have you had treatment now then?

[Monforte]

@EL
Since June 2014

[Bella1]

Keep standing, Monforte, - best wishes

[Bella1]

Where is your homearea?

[bibob]

MedWatch. https://medwatch.dk/Medicinal___Biotek/article11417856.ece

[E_L]

funny, Rajkumar just 'liked' my tweet on the Priority Review for Cassiopeia

[peter12]

He's watching you

[peter12]

Maybe he has an alias here ?

[polle1]

"nohope" ?

[E_L]

haha

[bibob]

Bob bob.

[bibob]

Maybe Bob Hope

[royal]

SC er som spar 5 i kortspillet Casino

[Relax]

Tak JKJ for at kontakte Andrew Carlsen. virkelig godt gået.

[Tandfeen-2]

Fra 1. Oktober sælger vi så også Dara til knoglemarv patienter? Hvis alt går vel. Hvordan påvirker det omsætning 2019? Og fremadrettet

[Thomas]

Tandfeen, hvis Genmab ikke sælger Dara til knoglemarvskræft allerede imorgen, så hedder kursen nok 300 Multiple myeloma er knoglemarvskræft

[Tandfeen-2]

:-), det jeg mente (som jeg troede var underforstået) var når de pr.1/10-19